These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 21609709
1. IgG subclass antibodies to three variants of Plasmodium falciparum merozoite surface protein-1 (PfMSP-1(19)) in an area with unstable malaria transmission in Iran. Mehrizi AA, Asgharpour S, Salmanian AH, Djadid ND, Zakeri S. Acta Trop; 2011 Aug; 119(2-3):84-90. PubMed ID: 21609709 [Abstract] [Full Text] [Related]
2. Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran. Rouhani M, Zakeri S, Mehrizi AA, Djadid ND. Malar J; 2015 Feb 05; 14():58. PubMed ID: 25652589 [Abstract] [Full Text] [Related]
3. Non-variant specific antibody responses to the C-terminal region of merozoite surface protein-1 of Plasmodium falciparum (PfMSP-1(19)) in Iranians exposed to unstable malaria transmission. Zakeri S, Mehrizi AA, Zoghi S, Djadid ND. Malar J; 2010 Sep 16; 9():257. PubMed ID: 20846388 [Abstract] [Full Text] [Related]
5. Analysis of Fcgamma receptor IIa (cd32) gene polymorphism and anti-malarial IgG subclass antibodies to asexual blood-stage antigen of Plasmodium falciparum in an unstable malaria endemic area of Iran. Zakeri S, Mashhadi R, Mehrizi AA, Djadid ND. Exp Parasitol; 2013 May 16; 134(1):115-21. PubMed ID: 23458236 [Abstract] [Full Text] [Related]
6. Plasmodium falciparum: sequence analysis of the gene encoding the C-terminus region of the merozoite surface protein-1, a potential malaria vaccine antigen, in Iranian clinical isolates. Mehrizi AA, Zakeri S, Salmanian AH, Sanati MH, Djadid ND. Exp Parasitol; 2008 Mar 16; 118(3):378-85. PubMed ID: 18053992 [Abstract] [Full Text] [Related]
7. Antibody responses and avidity of naturally acquired anti-Plasmodium vivax Duffy binding protein (PvDBP) antibodies in individuals from an area with unstable malaria transmission. Zakeri S, Babaeekhou L, Mehrizi AA, Abbasi M, Djadid ND. Am J Trop Med Hyg; 2011 Jun 16; 84(6):944-50. PubMed ID: 21633032 [Abstract] [Full Text] [Related]
9. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimurium. Bargieri DY, Leite JA, Lopes SC, Sbrogio-Almeida ME, Braga CJ, Ferreira LC, Soares IS, Costa FT, Rodrigues MM. Vaccine; 2010 Apr 01; 28(16):2818-26. PubMed ID: 20170765 [Abstract] [Full Text] [Related]
10. Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1. Shi YP, Sayed U, Qari SH, Roberts JM, Udhayakumar V, Oloo AJ, Hawley WA, Kaslow DC, Nahlen BL, Lal AA. Infect Immun; 1996 Jul 01; 64(7):2716-23. PubMed ID: 8698500 [Abstract] [Full Text] [Related]
11. Plasmodium falciparum: IgG subclass antibody response to merozoite surface protein-1 among Amazonian gold miners, in relation to infection status and disease expression. Scopel KK, Fontes CJ, Ferreira MU, Braga EM. Exp Parasitol; 2005 Feb 01; 109(2):124-34. PubMed ID: 15687019 [Abstract] [Full Text] [Related]
12. Human IgG subclass antibodies to the 19 kilodalton carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (MSP1(19)) and predominance of the MAD20 allelic type of MSP1 in Uganda. Apio B, Nalunkuma A, Okello D, Riley E, Egwang TG. East Afr Med J; 2000 Apr 01; 77(4):189-93. PubMed ID: 12858901 [Abstract] [Full Text] [Related]
13. Polymorphism and epitope sharing between the alleles of merozoite surface protein-1 of Plasmodium falciparum among Indian isolates. Mamillapalli A, Sunil S, Diwan SS, Sharma SK, Tyagi PK, Adak T, Joshi H, Malhotra P. Malar J; 2007 Jul 20; 6():95. PubMed ID: 17659072 [Abstract] [Full Text] [Related]
14. Immunogenicity and protective efficacy of Escherichia coli expressed Plasmodium falciparum merozoite surface protein-1(42) using human compatible adjuvants. Sachdeva S, Mohmmed A, Dasaradhi PV, Crabb BS, Katyal A, Malhotra P, Chauhan VS. Vaccine; 2006 Mar 15; 24(12):2007-16. PubMed ID: 16377036 [Abstract] [Full Text] [Related]
15. Pattern of humoral immune response to Plasmodium falciparum blood stages in individuals presenting different clinical expressions of malaria. Leoratti FM, Durlacher RR, Lacerda MV, Alecrim MG, Ferreira AW, Sanchez MC, Moraes SL. Malar J; 2008 Sep 24; 7():186. PubMed ID: 18816374 [Abstract] [Full Text] [Related]
17. [Differential changes in IgG1 and IgG3 against a major antigen of blood stage Plasmodium falciparum (MSP1(19)) as a function of the parasite transmission period: study among immune Senegalese adults]. Diallo TO, Tall A, Lochouarn L, Diouf A, Perraut R, Garraud O. Dakar Med; 2001 Sep 24; 46(2):125-8. PubMed ID: 15773179 [Abstract] [Full Text] [Related]
19. [Specific antibodies against Plasmodium falciparum antigens in immune subjects: II. Screening of responses against the merozoite major surface antigen (MSP!)]. Nguer CM, Diouf A, Diallo TO, Dieye A, Tall A, Diouf B, Molez JF, Trape JF, Perraut R, Garraud O. Dakar Med; 1997 Sep 24; 42(2):106-10. PubMed ID: 9827130 [Abstract] [Full Text] [Related]
20. Acquisition of antibodies to merozoite surface protein 3 among residents of Korogwe, north eastern Tanzania. Segeja MD, Mmbando BP, Seth MD, Lusingu JP, Lemnge MM. BMC Infect Dis; 2010 Mar 08; 10():55. PubMed ID: 20205959 [Abstract] [Full Text] [Related] Page: [Next] [New Search]